2023
DOI: 10.3390/ani13132084
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Autologous Microfragmented Adipose Tissue on Healing of Tibial Plateau Levelling Osteotomies in Dogs: A Prospective Clinical Trial

Luca Pennasilico,
Caterina Di Bella,
Sara Sassaroli
et al.

Abstract: The aim of this study was to evaluate the effects of autologous microfragmented adipose tissue (MFAT) applied after mechanical fragmentation and assess these effects radiographically in bone healing in dogs subjected to tibial plateau levelling osteotomy (TPLO). Twenty dogs with unilateral cranial cruciate ligament disease were enrolled and randomly assigned to the treatment group (MFAT) or the control group (NT). The MFAT group underwent TPLO and autologous MFAT intra-articular administration, while the NT gr… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 79 publications
0
2
0
Order By: Relevance
“…114 While research into MFATs impact on bone healing is still in its early phases, a preliminary animal trial has shown encouraging outcomes in canines who underwent tibial plateau osteotomy. 135 A protocol for a first in-human clinical study in alveolar cleft reconstruction has recently been described, aiming to assess the safety of utilizing MFAT to enhance the osteoinductive capacity of Biphasic Calcium Phosphate (BCP). 136 Supporting this direction, Benzi et al 115 have suggested that MFAT may be a safe and viable option to enhance bone regeneration in the setting of oral atrophy, though they emphasize the need for large-scale studies to validate this approach.…”
Section: Discussionmentioning
confidence: 99%
“…114 While research into MFATs impact on bone healing is still in its early phases, a preliminary animal trial has shown encouraging outcomes in canines who underwent tibial plateau osteotomy. 135 A protocol for a first in-human clinical study in alveolar cleft reconstruction has recently been described, aiming to assess the safety of utilizing MFAT to enhance the osteoinductive capacity of Biphasic Calcium Phosphate (BCP). 136 Supporting this direction, Benzi et al 115 have suggested that MFAT may be a safe and viable option to enhance bone regeneration in the setting of oral atrophy, though they emphasize the need for large-scale studies to validate this approach.…”
Section: Discussionmentioning
confidence: 99%
“…Bone TE: The ability of ADSCs to differentiate into osteoblasts and to produce various growth factors and cytokines that stimulate the proliferation and differentiation of osteoprogenitor cells is used in TE to regenerate bone tissue in cases of bone defects, fractures, nonunion or delayed union [131][132][133][134]. ADSCs have also been shown to promote angiogenesis, which is crucial for supplying nutrients and oxygen to the healing or degenerative bone, or ADSCs may enhance the activity of bone marrow stem cells, encouraging in this way bone regeneration [135][136][137]. Even more, ADSCs can be combined with scaffold materials to promote bone growth and reduce immune responses in allotransplantation [138,139].…”
Section: Regenerative Features and Utility In Tissue Engineeringmentioning
confidence: 99%